H.R.1794

Establishes an Abraham Accords Office within the Food and Drug Administration to enhance regulatory cooperation with countries that signed the.

The United States-Abraham Accords Cooperation and Security Act of 2025 amends the Federal Food, Drug, and Cosmetic Act to create an Abraham Accords Office within the Food and Drug Administration (FDA). This office will be headed by a director and will focus on providing technical assistance to regulatory partners in countries that have signed the Abraham Accords. The office will also facilitate interactions between the FDA and interested parties in these countries, including sharing information on U.S.